• Find People
  • Campus Map
  • PiratePort
  • A-Z
    • About
    • Submit
    • Browse
    • Login
    View Item 
    •   ScholarShip Home
    • Division of Health Sciences
    • Brody School of Medicine
    • Microbiology and Immunology
    • View Item
    •   ScholarShip Home
    • Division of Health Sciences
    • Brody School of Medicine
    • Microbiology and Immunology
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of The ScholarShipCommunities & CollectionsDateAuthorsTitlesSubjectsTypeDate SubmittedThis CollectionDateAuthorsTitlesSubjectsTypeDate Submitted

    My Account

    Login

    Statistics

    View Google Analytics Statistics

    Synergistic Effects of Selective Inhibitors Targeting the PI3K/AKT/mTOR Pathway or NUP214-ABL1 Fusion Protein in Human Acute Lymphoblastic Leukemia

    Thumbnail
    View/ Open
    McCubreySynergisticCytotoxicEffectsofBortezomibandCK2Inhibitor.pdf (4.546Mb)

    Show full item record
    
    Author
    McCubrey, James A.
    URI
    http://hdl.handle.net/10342/9629
    Subject
     NUP214-ABL1; PI3K/Akt/mTOR signaling; T-Acute Lymphoblastic Leukemia 
    Date
    2016-11-03
    Citation:
    APA:
    McCubrey, James A.. (November 2016). Synergistic Effects of Selective Inhibitors Targeting the PI3K/AKT/mTOR Pathway or NUP214-ABL1 Fusion Protein in Human Acute Lymphoblastic Leukemia. Oncotarget, (7:48), p.79842-79853. Retrieved from http://hdl.handle.net/10342/9629

    Display/Hide MLA, Chicago and APA citation formats.

    MLA:
    McCubrey, James A.. "Synergistic Effects of Selective Inhibitors Targeting the PI3K/AKT/mTOR Pathway or NUP214-ABL1 Fusion Protein in Human Acute Lymphoblastic Leukemia". Oncotarget. 7:48. (79842-79853.), November 2016. May 17, 2022. http://hdl.handle.net/10342/9629.
    Chicago:
    McCubrey, James A., "Synergistic Effects of Selective Inhibitors Targeting the PI3K/AKT/mTOR Pathway or NUP214-ABL1 Fusion Protein in Human Acute Lymphoblastic Leukemia," Oncotarget 7, no. 48 (November 2016), http://hdl.handle.net/10342/9629 (accessed May 17, 2022).
    AMA:
    McCubrey, James A.. Synergistic Effects of Selective Inhibitors Targeting the PI3K/AKT/mTOR Pathway or NUP214-ABL1 Fusion Protein in Human Acute Lymphoblastic Leukemia. Oncotarget. November 2016; 7(48) 79842-79853. http://hdl.handle.net/10342/9629. Accessed May 17, 2022.
    Collections
    • Microbiology and Immunology

    xmlui.ArtifactBrowser.ItemViewer.elsevier_entitlement

    East Carolina University has created ScholarShip, a digital archive for the scholarly output of the ECU community.

    • About
    • Contact Us
    • Send Feedback